Conference Coverage
Conference Coverage
IDWEEK: Cefazolin beats ceftriaxone for MSSA bacteremia treatment
Veteran patients treated with ceftriaxone for methicillin-susceptible Staphylococcus aureus bacteremia were more likely to have treatment failure...
Conference Coverage
Study characterizes injury risk in cervical myelopathy patients
Compared with age-matched controls, patients with cervical spondylotic myelopathy had a significantly increased incidence of falls, hip fractures...
Conference Coverage
FDA advisory committees support changing codeine contraindications for children
The FDA’s Pulmonary-Allergy Drugs and Drug Safety and Risk Management Advisory Committees voted strongly in favor of amending codeine’s current...
Conference Coverage
ACR: Don’t be fooled by contaminated synovial fluid
Hold off on surgery in patients with presumed septic arthritis if they’re not otherwise too sick and their cultures don’t grow out a pathogenic...
Conference Coverage
AHA: It’s best to have a cardiac arrest in Midwest
Substantial and as-yet unexplained regional differences in survival and total hospital charges following out-of-hospital cardiac arrest exist...
Conference Coverage
Glial fibrillary acidic protein may help identify youth with TBI
Glial fibrillary acidic protein appears to be a candidate biomarker for detecting traumatic intracranial lesions on head CT after mild to moderate...
Conference Coverage
VIDEO: Antigen test could simplify HCV screening
A new test focused on hepatitis C antigen detection might simplify the HCV screening process and reduce its costs.
Conference Coverage
VIDEO: Inappropriate hepatitis A, B tests may be widespread in hospitals
Hospital physicians may be ordering too many inappropriate lab tests in cases of suspected acute hepatitis A and hepatitis B.
Conference Coverage
Therapeutic hypothermia after nonshockable-rhythm cardiac arrest
Therapeutic hypothermia raises the rate of survival with a good neurologic outcome in comatose patients after a cardiac arrest with an...
Conference Coverage
Andexanet reverses anticoagulant effects of factor Xa inhibitors
Key clinical point:Andexanet reverses the anticoagulant effects of factor Xa inhibitors rivaroxaban and apixaban in healthy older adults.
Conference Coverage
Resistant gonorrhea rates high in China, raise concerns in U.S.
Recent sky high ceftriaxone resistance rates documented in gonococcal isolates in China bode ill for the current first-line treatment regimen in...